Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 23,076,000 | 21,836,000 | 20,371,900 | 18,633,500 | 15,691,000 |
| Cost of Goods | 4,366,200 | 4,247,000 | 4,376,700 | 4,248,800 | 3,546,500 |
| Gross Profit | 18,709,800 | 17,589,000 | 15,995,200 | 14,384,700 | 12,144,500 |
| Operating Expenses | 12,179,800 | 12,001,700 | 15,303,400 | 10,328,200 | 8,019,600 |
| Operating Income | 6,530,199 | 5,587,300 | 692,500 | 4,057,301 | 4,125,400 |
| Other Income | -4,999 | -229,500 | -2,000,100 | -180,501 | -707,400 |
| Pre-tax Income | 6,525,200 | 5,357,800 | -1,307,600 | 3,876,800 | 3,418,000 |
| Income Tax | 1,455,700 | 1,029,000 | 764,300 | 923,800 | 755,300 |
| Net Income Continuous | 5,069,500 | 4,328,800 | -2,071,900 | 2,953,000 | 2,662,700 |
| Net Income | $5,069,500 | $4,328,800 | $-2,071,900 | $2,953,000 | $2,662,700 |
| EPS Basic Total Ops | 4.58 | 3.94 | -1.89 | 2.71 | 2.45 |
| EPS Basic Continuous Ops | 4.58 | 3.94 | -1.89 | 2.71 | 2.45 |
| EPS Diluted Total Ops | 4.58 | 3.94 | -1.89 | 2.71 | 2.45 |
| EPS Diluted Continuous Ops | 4.58 | 3.94 | -1.89 | 2.71 | 2.45 |
| EBITDA(a) | $7,858,399 | $6,885,100 | $1,815,100 | $5,105,201 | $4,927,200 |